{
  "docId": "019dd923-622c-750b-8b9a-3bcd52c6e583",
  "docSlug": "f06b0b5d2079",
  "documentTitle": "Soleno Therapeutics (SLNO)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Scorpion Capital",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2025-08-15 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 286,
  "pageCount": 415,
  "prevPage": 285,
  "nextPage": 287,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "overcrowded",
  "nDataPoints": 0,
  "notes": "The slide uses highlighted text to emphasize key concerns about cardiac risk, genetic subtypes, and the drug's unknown mechanism of action.",
  "elementsJson": [
    "paragraph",
    "quote_block",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-3bcd52c6e583/286",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-3bcd52c6e583",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-3bcd52c6e583.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-3bcd52c6e583#slide-286",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "I have more than concern about [cardiac risk]. In fact, I’m writing an article on it...there’s an article that’s going to be coming out that I’ve written on this trial...I’ve been asked to write my opinion on this trial in the medical literature.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-64ce-7561-b2ae-1894ce18ee4e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.05,
        "y": 0.65
      },
      "kind": "paragraph",
      "text": "Working on journal paper related to cardiac risk; concerns around lack of understanding of the drug",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3d965992-d225-4f35-b33b-cfd4ef6ee566",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.05,
        "y": 0.22
      },
      "kind": "paragraph",
      "text": "Concerned about cardiac risk; upcoming paper; high vulnerability in common PWS genetic subtypes",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ab66cbbf-35a8-4274-89a2-b1e763780f0c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.9,
        "x": 0.05,
        "y": 0.39
      },
      "kind": "quote",
      "text": "Q: \"They also get peripheral edema. I heard two patients were hospitalized due to cardiac events, Do you have any concern around the cardiac risk of this drug?\" A: \"I have more than concern about it. In fact, I’m writing an article on it...\"",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "11d6dcda-5687-4a2a-9dad-11d3cfe2c406",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.9,
        "x": 0.05,
        "y": 0.71
      },
      "kind": "quote",
      "text": "Q: \"So, you're going to be talking about cardiac risk with Vykat?\" A: \"Yeah, lots of different issues that are going on.\" Q: \"It sounds like you feel there are things that need to be said...\" A: \"Well, I explain that in the paper that we still don't understand...\"",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a8d07cdf-acad-43c5-83c5-e8645921e696",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.9,
        "x": 0.05,
        "y": 0.28
      },
      "kind": "quote",
      "text": "Q: \"I heard one very concerning data point about the Vykat trials. Edema is a big side effect -\" A: \"Priapism is one of them, too. Which is edema of the sex organs. It can become painful to get edema in the penis or edema of the clitoris.\"",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "daf0800e-7b85-471b-b2c6-452b140cc967",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "I have more than concern about [cardiac risk]. In fact, I’m writing an article on it...there’s an article that’s going to be coming out that I’ve written on this trial...I’ve been asked to write my opinion on this trial in the medical literature...we still don’t have a clear understanding, even though the drug has been around since 1976. — Trial investigator and physician; one of the leading KOL’s in the PWS field",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-64ce-7561-b2ae-1dafa879c3c2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.3,
        "x": 0.05,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Source: Scorpion Capital consultation calls with experts",
      "attrs": {
        "numbered": true
      },
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d9397058-574b-4808-a2bc-702c75473a95",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Trial investigator #1 indicated that he’s working on a paper about cardiac risk from Vykat, and went into great detail about its genetic incompatibility with PWS patients",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d02c3747-a203-40ad-aba7-8619fff3ed53",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}